
 sntsplit:
Bioink 
The hydrogel was prepared by dissolving 4 w/v% alginate A1112- 
100G and 16 w/v% gelatin 39465-500G both from Sigma-Aldrich (St. 
Louis, United States) in PBS each.
 sntsplit:
Both 
stock solutions were mixed 1:1 to result in a hydrogel with 2 w/v% 
alginate and 8 w/v% gelatin.
 sntsplit:
A cell-laden hydrogel was prepared by 
gently mixing cells in a concentration of 500,000 cells/ml into the 37 â€¢C 
warm hydrogel.
 sntsplit:
Immortalized mesenchymal stem cells (iMSCs) were encapsulated in a 
hydrogel of 2% alginate and 8% gelatin in a concentration of 500,000 
cells/ml.
 sntsplit:
The hydrogel contained 500,000 cells/ml and the samples 
were incubated in vitro for up to 28 days.
 sntsplit:
After printing four layers ofthe scaffold (0.35 mm thickness), the bioink (25 lL;
1/C210
6cells mL/C01encapsulated in alginate, 2% w/v)
was injected into the scaffold in the selected points
(speed: 8 lL/s; 21 G nozzle).
 sntsplit:
HHSs were subject to a static condition without mechanical stimulation within 4 s in cell suspension (1 Ã— 106cells/mL), or a cycle of compressionrecovery within 4 s at 80% strain in hBMSCs cell suspension (1 Ã— 106cells/mL) under
a dynamic condition.
 sntsplit:
cSchematic diagram ( i),ï¬‚uorescence images ( ii) and quantitative analysis
(iii) of cell loading into HHSs in hBMSCs cell suspension (1 Ã— 10
6cells/mL), which
were controlled by various compression strains (20%, 40%, 60% and 80%), n=5 ,
*P= 0.0446 (20% and 40%), *** P=0 .
 sntsplit:
dSchematic diagram ( i),ï¬‚uorescence images ( ii)
and quantitative analysis ( iii) of cell loading into HHSs in hBMSCs cell suspension(5 Ã— 106cells/mL), which were controlled by number of cycles (1, 3, 5, and 10), n=8 ,
***P< 0.001.
 sntsplit:
Then, gelatin methacryloyl, Laponite nanoclay (BYK, Wesel),and N-acryloyl glycinamide (BD1188660, Bidepharm, China) were dis-solved in deionized water and adequately mixed at ï¬nal concentrations (w/v) of 12% gelatin methacryloyl, 10% Laponite nanocaly and 0%,4%, 8%, 12% N-acryloyl glycinamide to prepare the GLN0, GLN4, GLN8,and GLN12 hybrid inks, respectively.
 sntsplit:
Subsequently, the photoinitiator,
phenyl-2,4,6-trimethylbenzoyl phosphate lithium (TCI, L0290) was
added to a ï¬nal concentration of 0.1% (w/v).
 sntsplit:
Firstly, two approaches were used: The ï¬rst one was
direct immersion of HHSs in hBMSCs cell suspension (1 Ã— 106cells/mL)
for 4 s under a static condition; while the second one utilized acompression-recovery cycle in hBMSCs cell suspension under 80%
strain within 4 s ( V
1-mechanical response).
 sntsplit:
The number of cells loaded into HHSs were quanti ï¬ed by
ImageJ. Subsequently, the in ï¬‚uence of compression displacement
(20%, 40%, 60%, and 80%) in hBMSCs cell suspension (1 Ã— 10
6cells/mL)
and cycle times (1, 3, 5, and 10) under 40% compression displacementin hBMSCs cell suspension (5 Ã— 10
5cells/mL) on cell loading of HHSs
were also evaluated respectively.
 sntsplit:
Alginate was dissolved into deionized water at the concentration of 3% (w/v) and placed in ultrasonic water bath at 37 Â°C for 12 h to get the sodium alginate sol solutions.
 sntsplit:
Gelatin (5% w/v, 
Sigma-Aldrich) was added into alginate (Alginate/Gelatin, A/G) to improve the microenvironment of sol solutions for better cell survival
16.
 sntsplit:
Calcium chloride (CaCl2, Sigma-Aldrich, Shanghai, China) was dissolved into deionized water at a final concentration of 3% (w/v) (Supplemental Fig.
 sntsplit:
The print head contains two nozzles arranged in concentric circles and con-nected to different pumps, one to A/G hydrogel, and the other to high density cell suspension (1 Ã— 10
7/ml) in 3% 
fibrinogen (w/v) (CoF group).
 sntsplit:
180947, Sigma-Aldrich, St. Louis, MO, USA) was prepared at 2% w/vby
reconstituting in distilled water and sterilized using a 0.2 m syringe ï¬lter.
 sntsplit:
The ï¬nal concentration in the bioink
for ï¬brinogen, sodium alginate, and genipin was 20 mg/mL, 0.5% w/v, and 0.3 mg/mL,
respectively.
 sntsplit:
T7009, Sigma-Aldrich, St. Louis, MO, USA), and chitosan at
0.075% w/v(Cat.
 sntsplit:
The lyophilized GelMA (15% w/v),
BGM (5% w/v) and PI 2959 (0.5% w/v) were dissolved in deionized water to obtain a
homogenous ink.
 sntsplit:
A certain amount of SA (10% w/v) solution was added to the above
ink to improve its printability.
 sntsplit:
After the scaffolds were incubated in the cell
incubator for 30 min, the cell suspension (1 mL, 1 106cells/mL) was added on each
scaffold and incubated at 37C in 5% CO 2.
 sntsplit:
The quantitative analysis of ARS staining at day 21 was performed by adding 10% w/v
cetylpyridinium chloride (Sigma-Aldrich, Saint Louis, MO, USA), and the absorbance of
each well was detected at 562 nm.
 sntsplit:
The cell density in bio-inks was 1 107cells/mL. In order to improve the
biological activity of the scaffold, BMP-2 and PDGF were added into the bio-inks with a
ï¬nal concentration of 5 ug/mL and 100 ng/mL, respectively.
 sntsplit:
Preparation of cell-laden bioink
To prepare the cell-laden bioink, 20 mg/mL alginate and 30 mg/mL
PEO (A2P3) were dissolved in triple-distilled water and magnetically
stirred for 2 days at 4/C14C. Then, 1 /C2107cells/mL MSCs or SMCs were
added to the A2P3 solution.
 sntsplit:
The bioink was prepared by mixing a 2% alginate and 3% PEO
(A2P3) solution with MSCs and SMCs at 1 /C2107cells/mL. Alginate is a
biocompatible, non-toxic, and versatile polymer that enables rapid
gelation of the microstructure through the addition of cations [ 40].
 sntsplit:
13] reported the preparation of the hydrogels by using different formulations of gelatin (Gel), namely 3 w/v% and 5 w/v%, and 0.6 w/v% of xanthan gum (Xnt) for
heal ulcers.
 sntsplit:
The 2.5Gel3 and 3Gel4
printable hydrogels were gently mixed with 0.5 106ï¬broblasts/mL and 5 106HaCaT
cells/mL, respectively, using two syringes connected under a sterile cap.
 sntsplit:
Among all the hydrogel formulations modulating
the process and the parameters of the 3D printer, the 2.5 w/v% and 3 w/v% of gelatin
with 1.2 w/v% xanthan gum resulted in being printable, with a good resolution.
 sntsplit:
The dermis 
was cut into small pieces in a 35 mm petri dish, 
treated with 0.35% (w/v) Dispase II, and incubated 
for 60 min at 37Â°C.
 sntsplit:
2.2 Preparation of bio-link
Bio-ink used in this study was formulated as 
a mixture of 5% (w/v) gelatin (Sigma-Aldrich), 
1% alginate (Sigma-Aldrich), and 2 mg/ml fibrino gen (Sigma-Aldrich).
 sntsplit:
After the dermal layer constructs were printed, 
they were crosslinked by sterile 2% (w/v) CaCl 2.
 sntsplit:
In light of such results, 
the bio-ink consisting of 5% (w/v) gelatin, 1% 
alginate, and 2 mg/ml fibrinogen was chosen for 
subsequent bioprinting experiments.
 sntsplit:
In this work, based 
on these previous reports and in consideration of 
the desirable properties, a brand-new bio-ink that 
contains 5% (w/v) gelatin, 1% alginate, and 2 mg/ 
ml fibrinogen was selected through a great number 
of tests.
 sntsplit:
Human adipose-derived mesenchymal stem cells (ASCs) 
were uniformly mixed in this bioink at 1 Ã— 106 cells/mL concentration, and spheroid 
specimens were cultured in both static and dynamic culture conditions.
 sntsplit:
Bioink preparation
Gelatin (Type B, Sigma-Aldrich, St. Louis, MO, USA) 
in 3 w/v % (0.3 g in 10 mL) was dissolved in Dulbeccoâ€™s 
Modified Eagle Medium (DMEM; Gibco, Thermo Fisher 
Scientific, MA, USA) in a glass beaker at ~40Â°C while being 
magnetically stirred at 150 rpm.
 sntsplit:
After gelatin dissolution, 
sodium alginate (Sigma-Aldrich, St. Louis, MO, USA) in 3 
w/v % (0.3 g in 10 mL) was added to the gelatin solution 
and mixed overnight to obtain the AG hydrogel.
 sntsplit:
B3 glass 
powder particles (less than 20 Âµm with ~3 Âµm d50 particle 
size; chemical composition in wt.%: 53% B2O3, 20% CaO, 
12% K2O, 6% Na2O, 5% MgO, 4% P2O5) were added to the 
solution in four different weight ratios (0.075, 0.15, 0.3, and 
0.6 w/v %) after gelatin dissolution and allowed to dissolve 
for ~10 min before the addition of alginate powder.
 sntsplit:
For 
example, 0.075 w/v % B3 glass corresponds to 1.25% 
of total combined weight of alginate and gelatin in the 
solution.
 sntsplit:
Therefore, AG hydrogels made with 0.075, 0.15, 
0.3, and 0.6 w/v % B3 glass are referred as 1.25G, 2.5G, 5G, 
and 10G, respectively, in this paper.
 sntsplit:
Rheological characterization
For rheological characterization, hydrogels were prepared 
in deionized (DI) water with gelatin (3 w/v %), alginate 
(3 w/v %), and AG (6 w/v %), and with the addition of 
B3 glass in different weight concentrations.
 sntsplit:
These findings suggest 
the likelihood of an optimal B3 glass concentration, ranging 
between 1.25 and 2.5 wt.%, for AG hydrogels composed of 3 
w/v % alginate and 3 w/v % gelatin.
 sntsplit:
AG hydrogel 
strength greatly depends on the w/v % of the alginate and 
gelatin used in the preparation and the ionic strength of 
the crosslinking solution.
 sntsplit:
used 6 
w/v % of alginate and gelatin (compared to 3 w/v % used 
in our study), and the crosslinked samples with 0.3 M 
CaCl2 (compared to 0.1 M CaCl2 in our study) reported 
improved mechanical properties that were able to sustain 
for up to 7 days in culture conditions.14 Our attempts to 
test specimens after soaking them in DMEM for 7 days 
at culture conditions were not successful as specimens 
were broken in the grips of the Instron machine, and 
insignificant elastic modulus and strength values were 
recorded.
 sntsplit:
The ASC viability in spheroidal culture helped 
determine the range of viable B3 glass percentages that 
could be added to AG hydrogel (0.075 and 0.15 w/v % or 
1.25G and 2.5G gels) and the suitable culture conditions 
(dynamic better than static).
 sntsplit:
Rheological 
properties of an AG hydrogel were modified with the 
addition of 0.075 to 0.6 w/v % of highly resorbable B3 glass, 
and scaffolds were successfully fabricated.
 sntsplit:
The addition of 
B3 glass (0.075 and 0.15 w/v %) increased the viscosity 
(from 0.2 kPaÂ·s to 7 kPaÂ·s) and made the AG hydrogel exhibit a viscoelastic solid-like behavior (Gâ€™> Gâ€™â€™) that 
improved the hydrogel recovery and enabled effortless 
extrusion 3D printing of scaffolds.
 sntsplit:
Despite the toxicity of B3 to ASCs when 
added in quantities higher than 0.3 w/v % to hydrogel 
(<70% viable ASCs), lower quantities of B3 have increased 
the viability in comparison to AG hydrogels without B3 
after 7 days in culture (>80% viable ASCs).
 sntsplit:
In the first place, 10 mg of PI was dissolved in 1 mL of 0.1M 
HEPES buffer solution in order to gain a solid content with 1% (w/v) concentration.
 sntsplit:
Then, 
200 mg GelMA foam was added to this solution to get 20% (w/v) GelMA stock solution.
 sntsplit:
The heart 
pieces were then digested in a solution of 0.06% (w/v) trypsin (Sigma-Aldrich) in HBSS 
overnight (4Â°C).
 sntsplit:
O 2 releasing bioinks were produced using 10% 
GelMA, containing CPO in varying concentrations (w/v) of 0.1% (0.1 CPO), 0.5% (0.5 
CPO), 1% (1.0 CPO), or 0% (0 CPO) with HEPES-HCl buffer, according to the protocol 
presented in Table 1 [ 29].
 sntsplit:
RFP-HUVECs were either suspended alone or with hADSCs at a 2:1 ratio for a total cell 
density of 5 million cells/mL in each alginate solution.
 sntsplit:
HUVECs and hADSCs were stained with Calcein-AM before 
being suspended 2:1 in partially crosslinked alginate at a total density of 3 million cells/mL 
and pipetted into the glass tips.
 sntsplit:
To fabricate a heterogenous VTU, 
RFP-HUVECs and hADSCs were suspended in the vasculogenic bioink in a 2:1 ratio (RFPHUVEC:ADSC) at a total cell density of 5 million cells/mL. To fabricate a mixed VTU, 
RFP-HUVECs, hADSCs, and GFP-hDFs were suspended in the vasculogenic bioink in a 
2:1:1 ratio (RFP-HUVEC:ADSC:GFP-hDF) at a total cell density of 5 million cells/mL. For 
both heterogenous and mixed VTUs, GFP-hDFs were loaded at a density of 2 million 
cells/mL in the fibroblast-containing bioink.
 sntsplit:
B) Storage and loss modulus of peptide-functionalized (2% 
w/v) alginates measured by oscillatory frequency sweep from 0.1 to 10 Hz at 1% strain; nâ‰¥4 
for each group; n.s.
 sntsplit:
A) Representative 
day 7 images of RFP-HUVECs cultured with or without ADSCs in 2% (w/v) peptidefunctionalized alginates. (
 sntsplit:
E) Microvascularization at day 14 in 2% (w/v) alginates Barrs et al.
 sntsplit:
A) Increasing concentrations of CaCl 2 (0â€“20 mM) were added to 2% (w/v) 
alginate hydrogel precursors to yield progressively crosslinked solutions. (
 sntsplit:
A) Cell 
sedimentation test in 2% (w/v) alginates that were or were not partially crosslinked with 15 
mM CaCl 2.
 sntsplit:
Immediate Cell Viability after Bioprinting
To investigate the immediate cell viability after bioprinting, MC3T3 pre-osteoblast cells 
were bioprinted at a density of 1 Ã— 106 cells/mL of bioink.
 sntsplit:
Author Manuscript Author Manuscript Author Manuscript Author Manuscript2.6 Bone Cell Proliferation
To investigate the long-term cell viability and proliferation in the bioprinted hydrogel, 
MC3T3 pre-osteoblast cells were bioprinted at a density of 10 Ã— 106 cells/mL of bioink.
 sntsplit:
After reaching 80% confluency, PC12 cells were trypsinized and centrifuged at 3000 
rpm for 10 min and mixed into bioink at a density of 10 Ã— 106 cells/mL using the same 
procedure as described in the MC3T3 cell mixing section.
 sntsplit:
Author Manuscript Author Manuscript Author Manuscript Author Manuscriptcollected by centrifugation and mixed with OPF/Gelatin slurry (1 Ã— 106 cells/mL) to make 
bioinks, as presented in Fig.
 sntsplit:
b) Microscopic images of the same printed scaffolds at different positions of 
the scaffolds and c) enlarged microscopic images of the scaffolds containing cells (1 Ã— 
106 cells/mL of bioink).
 sntsplit:
Briefly, 56% (w/v) Î²glycerophosphate ( Î²GP, Sigma-Aldrich) combined with 2% (w/v) chitosan solution (CS, 
Sigma-Aldrich, cat.
 sntsplit:
The constructs were 3D bioprinted (using transfected or 
non-transfected hMSCs at 5 million cells/mL loaded into the bioink) at a bioprinting 
speed of 60 mm/min, a nozzle diameter of 410 Î¼m and pneumatic pressure of 80 kPa.
 sntsplit:
The experiment was designed to include four major groups: i) negative control ( n=3), ii) 
bioink+rBMSCs (5 million cells/ml) ( n=6), iii) bioink+rBMSCs(tPEI-pBMP-2) ( n=6) for 
ex-situ delivery, and iv) bioink+PEI-pBMP-2 ( n=7) for in-situ delivery of plasmid particles.
 sntsplit:
For in-vitro evaluation, hMSCs were used at a 
density of 5 million cells/mL in the bioink.
 sntsplit:
In this study, we used 5Ã—106 rBMSCs per mL, where the cell encapsulation density for 
hydrogels has been varied from 5 to 10 million cells/ml for bone tissue engineering [ 45].
 sntsplit:
For instance, among collagen constructs seeded with 
6 Ã— 105, 3 Ã— 106, 3 Ã— 107, and 1 Ã— 108 cells/mL, a scaffold with cell density above 3 
Ã— 106 cells/mL revealed a significant decrease in break force when tensile testing was 
performed immediately after compression at Day 10 [ 52].